Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $44.98 ($1.8M) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Seasonal sale ($1.8M) by Chief Executive Officer — this insider has traded FGEN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.98 | 10,700 | $481K | 26.7% |
| 2 | $45.04 | 1,118 | $50K | 2.8% |
| 3 | $45.59 | 7,700 | $351K | 19.5% |
| 4 | $45.67 | 300 | $14K | 0.8% |
| 5 | $45.31 | 918 | $42K | 2.3% |
| 6 | $45.33 | 11,500 |
| $521K |
| 28.9% |
| 7 | $46.17 | 500 | $23K | 1.3% |
| 8 | $46.19 | 6,900 | $319K | 17.7% |
| Total | $45.44 avg | 39,636 | $1.8M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-07 | $1.5M | — | Filing → |